Health & Medicine
-
Tobacco Plants Used to Develop a COVID-19 Vaccine
In an interview conducted by Technology Networks to the Scientific Research Director of British American Tobacco (BAT), David O'Reilly, PhD, it was confirmed that there was an undergoing preclinical testing for COVID-19 vaccine using tobacco plant as a "biomanufacturing factory". This simply means that tobacco plants were being used as a vessel where a key protein from the coronavirus is being processed so that it can be used in developing a vaccine.
Latest Research Articles
-
Countries Who Will Fail to Cut Reliance in Coal Will "Hear From the US"
-
Plastics Used as Biodegradable Surfactant: Good or Bad Sustainability Solution?
-
Global Water Crisis Can Be Solved By An Unlikely Ally -- Sunlight!
-
AI and Satellites Can Help Identify Pollution Hotspots, Researchers Show
-
Human to Nonhuman Chimeras Discussion Resurfaces After Monkey Embryos Established to Have Human Cells
-
Magic Mushroom Compound Can Be the Future Treatment for Depression
-
Carbon Cutting: 3 Innovative Ideas To Reduce Harmful Emission
-
Humans 10x Better Than Chimps and Macaques When It Comes to Temperature Control
-
France Aims to Cut Emissions By Banning Short Flights
-
To Achieve Climate Goal, China Must Shut Down 600 Coal-Fired Plants Within 10 Years
-
5 Common Houseplants that are Actually Lethal